Abstract
Acute kidney injury (AKI) is one of the most common complications following cardiothoracic surgery and is independently associated with increased morbidity and mortality. Serum creatinine and urine output, the current gold standards, do not provide effective early risk stratification which has led to intense investigation of several novel biomarkers of AKI. This chapter will discuss the literature around pre and post-operative biomarkers of cardiothoracic surgery associated AKI focusing on several novel assays including Neutrophil Gelatinase Associated Lipocalin (NGAL) and Tissue injury metalloprotease-2 insulin-like growth factor binding protein-7 (TIMP2-IGFBP7). We discuss the wealth of prospective observational data that demonstrates these biomarkers can accurately detect AKI and the need for renal replacement therapy earlier than serum creatinine. Additionally, we will discuss the clinical utility and interpretation of these tests as well as discuss the limited randomized data demonstrates that utilizing elevated post-operative biomarkers, prior to a rise in serum creatinine, to trigger a nephrology-focused care bundle can improve outcomes following cardiac surgery.
COI – JLK reports receiving funds from Astute Medical, Abbvie and Bioporto for the enrollment of patients into cardiac surgery associated acute kidney injury clinical studies. JLK has received consulting fees from Astute Medical and Sphingotec.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parikh CR, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol. 2011;22(9):1748–57.
Gunnerson KJ, et al. TIMP2*IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg. 2016;80(2):243–9.
Meersch M, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551–61.
Waikar SS, et al. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012;23(1):13–21.
Kashani K, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25.
Parikh CR, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013;8:1079–88.
Zarbock A, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313(21):2133–41.
Bellomo R, et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–12.
KDIGO, Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2(Supp):1–138.
Chawla LS, et al. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–57.
Park M, et al. Association of peak changes in plasma cystatin C and creatinine with death after cardiac operations. Ann Thorac Surg. 2016;101(4):1395–401.
Mishra J, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–8.
Koyner JL, et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol. 2012;23(5):905–14.
Coca SG, et al. First post-operative urinary kidney injury biomarkers and association with the duration of AKI in the TRIBE-AKI cohort. PLoS One. 2016;11(8):e0161098.
Zarbock A, et al. Long-term effects of remote ischemic preconditioning on kidney function in high-risk cardiac surgery patients: follow-up results from the RenalRIP trial. Anesthesiology. 2017;126(5):787–98.
Moledina DG, et al. Association of perioperative plasma neutrophil gelatinase-associated lipocalin levels with 3-year mortality after cardiac surgery: a prospective observational cohort study. PLoS One. 2015;10(6):e0129619.
Haase M, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57(17):1752–61.
Meersch M, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014;9(3):e93460.
Koyner JL, et al. Urinary cystatin C and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2013;61(5):730–8.
Shlipak MG, et al. Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis. 2011;58(3):366–73.
Spahillari A, et al. Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. Am J Kidney Dis. 2012;60(6):922–9.
Wu VC, et al. Preoperative proteinuria is associated with long-term progression to chronic dialysis and mortality after coronary artery bypass grafting surgery. PLoS One. 2012;7(1):e27687.
George LK, et al. Association of pre-operative albuminuria with post-operative outcomes after coronary artery bypass grafting. Sci Rep. 2015;5:16458.
Coca SG, et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2012;143(2):495–502.
Nadkarni GN, et al. Urinalysis findings and urinary kidney injury biomarker concentrations. BMC Nephrol. 2017;18(1):218.
Molnar AO, et al. Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk. Clin J Am Soc Nephrol. 2012;7(11):1749–60.
Coca SG, et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol. 2014;25(5):1063–71.
Parikh CR, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013;8(7):1079–88.
Gocze I, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study. Ann Surg. 2017;265:874.
Koyner JL, Parikh CR. Clinical utility of biomarkers of AKI in cardiac surgery and critical illness. Clin J Am Soc Nephrol. 2013;8(6):1034–42.
Endre ZE, Kellum JA, et al. Contrib Nephrol. Basel, Karger. 2013;182:30–44.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Koyner, J.L. (2019). Role of Biomarkers in Predicting AKI in the CT ICU. In: Lonchyna, V. (eds) Difficult Decisions in Cardiothoracic Critical Care Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-04146-5_36
Download citation
DOI: https://doi.org/10.1007/978-3-030-04146-5_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04145-8
Online ISBN: 978-3-030-04146-5
eBook Packages: MedicineMedicine (R0)